Oliveira et al. (2021) reported in their study of 178 patients having either breast or ovarian cancer who applied for genetic testing that the severity of their anxiety was greater than that of their depression, and that the presence of BRCA1/2 mutation did not affect either anxiety or depression levels [17]. The gene discussed is BRCA1; the disease is depressive symptom measurement.